Back to
Jacobs Levy Equity Management, Inc.
TNGX
12 quarters
Position history for
Jacobs Levy Equity Management, Inc.'s holdings in Tango Therapeutics, Inc.
No. Jacobs Levy Equity Management exited its TNGX (Tango Therapeutics) position in Q3 2025. Its Q2 2025 13F listed 218,779 shares worth $1.1M. Jacobs Levy Equity Management first reported TNGX in Q3 2022 and held it in 10 quarterly 13F filings.
Final Value
$0
Final Shares
0
Total Value Change
-$1.3M
Total Shares Change
-345,923
Quarter-by-Quarter History
Other major holders of TNGX: RTW Investments, LP, BlackRock, Inc., FMR LLC, Farallon Capital Management, L.L.C., Goldman Sachs Group Inc.